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Background 
Mycoplasma bovis has traditionally been diagnosed with 
bacterial culture, but this is time consuming and expensive. 
Antibody measurements are cheap and readily available, 
but the relationship between clinical signs and antibody 
response in individual animals is not currently understood. 
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Results 
SVEPM 2017 Inverness, Scotland 
Methods Blood and milk sampling for antibody 
measurements and clinical examination, 
done 5 times, 3 weeks apart (~3 months) 
4 Danish dairy herds  
with acute outbreaks of   
Mycoplasma bovis 
associated disease  
4 clinical groups 
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Arthritis 
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Blood samples 
 
• Substantial variation 
between cows 
• Variation between 
clinical groups 
• Antibodies very 
dynamic compared 
to other diseases 
Milk samples 
 
• Only useful for cows 
with mastitis 
• Very short-lived, but 
substantial rise in 
antibodies 
• Antibodies very 
dynamic compared 
to other diseases 
 
 
Substantial variation between cows, even within groups with similar clinical signs of Mycoplasma bovis.  
The differences between groups might be useful for group diagnostics. Control herds need investigation  
Study objective 
To compare the development and variation in 
the dynamics of antibody responses to 
Mycoplasma bovis  in groups of cows with 
different clinical signs 
 
Linear mixed model: 
herd and cow as 
random effects 
Outcome:  
Mycoplasma bovis 
BioX K302 ELISA-
values (ODC%) 
 
Conclusions 
Outbreak 
start 
Weeks 1 2 5 4 3 
First visit in the 4 herds 
